EPO: Appeal Board vetoes EPC regulation

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO: Appeal Board vetoes EPC regulation

Veto final

In the latest international briefing for the EPO, Jakob Pade Frederiksen looks at the law around the patenting of plant and animal varieties as well as biological processes for the production of plants and animals

Following the so-called Tomato II and Broccoli II decisions rendered by the EPO's Enlarged Board of Appeal (EBA) in 2015, the politically delicate question of patentability of plant or animal varieties as well as essentially biological processes for the production of plants or animals has once again occupied the EPO, now with the uncomfortable implication that a Technical Board of Appeal of the EPO has revealed a conflict between two legal provisions within the framework of the EPC.

The Tomato II and Broccoli II decisions, G 2/12 and G 2/13, held that products derived from essentially biological processes may be patentable, even if the process used to obtain the product is essentially biological and hence not patentable. In particular, the EBA concluded that Article 53(b) EPC, excluding plant or animal varieties and essentially biological processes for the production of plants or animals from patentability, did not extend to plants or plant material or plant parts other than a plant variety.

In the wake of these decisions, the European Commission released a notice in November 2016 stating that the EU legislator's intention when adopting the Biotech Directive (98/44/EC) was to exclude from patentability plants, animals and parts thereof obtained by means of essentially biological processes. Against this background, the Administrative Council of the EPO implemented as of July 1 2017 new Rule 28(2) EPC specifying that under Article 53(b) EPC, "European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process."

According to decision T 1063/18 concerning the refusal under Rule 28(2) EPC of EP 2 753 168, made available on February 5 2019, a Technical Board of Appeal of the EPO held that Rule 28(2) EPC is in conflict with Article 53(b) EPC, as interpreted by the EBA in the above-referred decisions. In accordance with Article 164(2) EPC, the Appeal Board held that the provisions of the convention, i.e. Article 53(b) EPC shall prevail. In other words, Rule 28(2) is null and void.

Given the public interest in the matter concerned and the ethical aspects involved, and having regard to political signals from relevant EU bodies, it seems likely that further legislative initiatives may soon be taken in order to resolve the conflict between EU legislators' views and the provisions of Article 53(b) EPC.

frederiksen.jpg

Jakob Pade Frederiksen

Inspicos P/S

Kogle Allé 2

DK-2970 Hoersholm

Copenhagen, Denmark

Tel: +45 7070 2422

Fax: +45 7070 2423

info@inspicos.com

www.inspicos.com

more from across site and ros bottom lb

More from across our site

Chris Sleep, Abion’s new head of litigation and dispute management, will work in the firm’s London office
Sources at four firms explain how changes to USPTO fees provide opportunities to give clients strategic counselling
An intervention by Dyson into the UK’s patent box regime and a report unveiling the major SEP owners were among the big talking points this week
With the threshold for proving copyright infringement by AI tools clearer than ever, 2025 could answer some of the key questions
Partners at Latham & Watkins and Finnegan reveal how they helped explain their client’s technology to a jury
One of Managing IP’s most influential people in IP for 2024, Hurtado Rivas discusses mental health in the profession, the changing role of a trademark lawyer, and what keeps a Nestlé IP counsel busy
Transactions specialist Mathilda Davidson, who has joined from Gowling WLG, says the firm will help clients seeking venture capital investment
Sources in the US, UK, and Australia hope that pressing questions surrounding AI and patent eligibility will finally be answered this year
Two partners who joined Brown Rudnick last year explain how their new firm’s venture capital experience is helping them accomplish their goals
Michael Gaertner explains why Locke Lord’s merger with Troutman Pepper sparked the need to seek a new home and why Buchanan Ingersoll & Rooney ticked the right boxes
Gift this article